VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From
Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: mktime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45

Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45
Jun 01, 2017 To
Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /data/var/www/html/violinet/litesearch/vaxlert/content.php on line 45
Jun 28, 2017:

Brucella (Brucellosis)

  1. Cleaveland S, Sharp J, Abela-Ridder B, Allan KJ, Buza J, Crump JA, Davis A, Del Rio Vilas VJ, de Glanville WA, Kazwala RR, Kibona T, Lankester FJ, Lugelo A, Mmbaga BT, Rubach MP, Swai ES, Waldman L, Haydon DT, Hampson K, Halliday JEB. One Health contributions towards more effective and equitable approaches to health in low- and middle-income countries Philosophical transactions of the Royal Society of London. Series B, Biological sciences 372(1725) 2017 [PMID: 28584176]
  2. Zeng J, Duoji C, Yuan Z, Yuzhen S, Fan W, Tian L, Cai C, Robertson I. Seroprevalence and risk factors for bovine brucellosis in domestic yaks (Bos grunniens) in Tibet, China Tropical animal health and production 2017 [PMID: 28624927]
  3. Lalsiamthara J, Lee JH. Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge Veterinary microbiology 205:84-91 2017 [PMID: 28622869]

Burkholderia pseudomallei (Melioidosis)

  1. Krishnananthasivam S, Jayathilaka N, Sathkumara HD, Corea E, Natesan M, De Silva AD. Host gene expression analysis in Sri Lankan melioidosis patients PLoS neglected tropical diseases 11(6):e0005643 2017 [PMID: 28628607]

Chlamydia psittaci (Psittacosis)

  1. Chan J, Doyle B, Branley J, Sheppeard V, Gabor M, Viney K, Quinn H, Janover O, McCready M, Heller J. An outbreak of psittacosis at a veterinary school demonstrating a novel source of infection One health (Amsterdam, Netherlands) 3:29-33 2017 [PMID: 28616500]

Clostridium perfringens

  1. Vinogradov E, Aubry A, Logan SM. Structural characterization of wall and lipidated polysaccharides from Clostridium perfringens ATCC 13124 Carbohydrate research 448:88-94 2017 [PMID: 28628892]
  2. Zhao L, Guo Z, Liu J, Wang Z, Wang R, Li Y, Wang L, Xu Y, Tang L, Qiao X. Recombinant Lactobacillus casei expressing Clostridium perfringens toxoids α, β2, ε and β1 gives protection against Clostridium perfringens in rabbits Vaccine 2017 [PMID: 28625525]

Coxiella burnetii (Q fever)

  1. Cleaveland S, Sharp J, Abela-Ridder B, Allan KJ, Buza J, Crump JA, Davis A, Del Rio Vilas VJ, de Glanville WA, Kazwala RR, Kibona T, Lankester FJ, Lugelo A, Mmbaga BT, Rubach MP, Swai ES, Waldman L, Haydon DT, Hampson K, Halliday JEB. One Health contributions towards more effective and equitable approaches to health in low- and middle-income countries Philosophical transactions of the Royal Society of London. Series B, Biological sciences 372(1725) 2017 [PMID: 28584176]
  2. Lower T, Corben P, Massey P, Depczynski J, Brown T, Stanley P, Osbourn M, Durrheim D. Farmers' knowledge of Q fever and prevention approaches in New South Wales The Australian journal of rural health 2017 [PMID: 28618042]

Cryptosporidium parvum

  1. Manjunatha UH, Vinayak S, Zambriski JA, Chao AT, Sy T, Noble CG, Bonamy GMC, Kondreddi RR, Zou B, Gedeck P, Brooks CF, Herbert GT, Sateriale A, Tandel J, Noh S, Lakshminarayana SB, Lim SH, Goodman LB, Bodenreider C, Feng G, Zhang L, Blasco F, Wagner J, Leong FJ, Striepen B, Diagana TT. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis Nature 546(7658):376-380 2017 [PMID: 28562588]
  2. Huang Y, Cao W, Shi K, Mi R, Lu K, Han X, Chen Z. Protective efficacy of recombinant Cryptosporidium parvum CpPRP1 sushi domain against C. tyzzeri infection in mice Parasite immunology 2017 [PMID: 28599077]

Ebola virus

  1. ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, Rudge TL, Sabourin C, Silvera P, Hooper JW, Kwilas SA, Kilgore N, Badorrek C, Ramsey WJ, Heppner DG, Kemp T, Monath TP, Nowak T, McNeil SA, Langley JM, Halperin SA. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 189(24):E819-E827 2017 [PMID: 28630358]
  2. Lennemann NJ, Herbert AS, Brouillette R, Rhein B, Bakken RA, Perschbacher KJ, Cooney AL, Miller-Hunt CL, Ten Eyck P, Biggins J, Olinger G, Dye JM, Maury W. Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice Journal of virology 2017 [PMID: 28615211]
  3. Pierson JF, Kirchoff MC, Tyee RT, Montello MJ, Rhie JK. Establishment of a research pharmacy to support Ebola clinical research in Liberia Journal of the American Pharmacists Association : JAPhA 2017 [PMID: 28610940]
  4. Clarke EC, Bradfute SB. Advances in Ebola virus vaccination The Lancet. Infectious diseases 2017 [PMID: 28606592]
  5. Heppner DG Jr, Kemp TL, Martin BK, Ramsey WJ, Nichols R, Dasen EJ, Link CJ, Das R, Xu ZJ, Sheldon EA, Nowak TA, Monath TP. Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study The Lancet. Infectious diseases 2017 [PMID: 28606591]
  6. Cooper CL, Martins KA, Stronsky SM, Langan DP, Steffens J, Van Tongeren S, Bavari S. T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection Emerging microbes & infections 6(6):e46 2017 [PMID: 28588288]
  7. Duehr J, Wohlbold TJ, Oestereich L, Chromikova V, Amanat F, Rajendran M, Gomez-Medina S, Mena I, TenOever BR, García-Sastre A, Basler CF, Munoz-Fontela C, Krammer F. Novel cross-reactive monoclonal antibodies against Ebolavirus glycoproteins show protection in a murine challenge model Journal of virology 2017 [PMID: 28592526]
  8. Bounds CE, Terry FE, Moise L, Hannaman D, Martin WD, De Groot AS, Suschak JJ, Dupuy LC, Schmaljohn CS. An immunoinformatics-derived DNA vaccine encoding human Class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice Human vaccines & immunotherapeutics :0 2017 [PMID: 28575582]
  9. Song X, Lu LY, Passioura T, Suga H. Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5 Organic & biomolecular chemistry 2017 [PMID: 28574091]
  10. Wolfe CM, Hamblion EL, Schulte J, Williams P, Koryon A, Enders J, Sanor V, Wapoe Y, Kwayon D, Blackley DJ, Laney AS, Weston EJ, Dokubo EK, Davies-Wayne G, Wendland A, Daw VTS, Badini M, Clement P, Mahmoud N, Williams D, Gasasira A, Nyenswah TG, Fallah M. Ebola virus disease contact tracing activities, lessons learned and best practices during the Duport Road outbreak in Monrovia, Liberia, November 2015 PLoS neglected tropical diseases 11(6):e0005597 2017 [PMID: 28575034]
  11. Gilbert SC, Warimwe GM. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology Vaccine 2017 [PMID: 28576573]
  12. Vergara-Alert J, Vidal E, Bensaid A, Segalés J. Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus One health (Amsterdam, Netherlands) 3:34-40 2017 [PMID: 28616501]
  13. Furuyama W, Miyamoto H, Yoshida R, Takada A. Quantification of Filovirus Glycoprotein-Specific Antibodies Methods in molecular biology (Clifton, N.J.) 1628:309-320 2017 [PMID: 28573631]
  14. Mire CE, Geisbert TW. Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate Models Methods in molecular biology (Clifton, N.J.) 1628:293-307 2017 [PMID: 28573630]
  15. Marzi A. Evaluation of Ebola Virus Countermeasures in Guinea Pigs Methods in molecular biology (Clifton, N.J.) 1628:283-291 2017 [PMID: 28573629]
  16. Kroeker A, Griffin BD, Qiu X, Kobinger G. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection Methods in molecular biology (Clifton, N.J.) 1628:273-282 2017 [PMID: 28573628]
  17. Falzarano D. Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds Methods in molecular biology (Clifton, N.J.) 1628:203-210 2017 [PMID: 28573622]
  18. Reynard O, Mateo M. Modeling Ebolavirus Budding with Virus Like Particles Methods in molecular biology (Clifton, N.J.) 1628:109-117 2017 [PMID: 28573614]

Escherichia coli

  1. Shim SM, Song EJ, Song D, Lee TY, Kim DJ, Nam JH, Gwin Jeong D, Lee CK, Kim SH, Kim JK. Nontoxic outer membrane vesicles efficiently increase the efficacy of an influenza vaccine in mice and ferrets Vaccine 35(30):3741-3748 2017 [PMID: 28576571]
  2. Richard E, Pifferi C, Fiore M, Samain E, Le Gouellec A, Fort S, Renaudet O, Priem B. Chemo-bacterial synthesis of a sialyl-Tn cyclopeptide vaccine candidate Chembiochem : a European journal of chemical biology 2017 [PMID: 28632300]
  3. Leach S, Lundgren A, Carlin N, Löfstrand M, Svennerholm AM. Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent enterotoxigenicEscherichia coli (ETEC) vaccine ETVAX Vaccine 2017 [PMID: 28625524]
  4. Watad A, Azrielant S, Bragazzi NL, Sharif K, David P, Katz I, Aljadeff G, Quaresma M, Tanay G, Adawi M, Amital H, Shoenfeld Y. Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity Journal of autoimmunity 2017 [PMID: 28624334]
  5. Perera N, Yang FL, Chang CM, Lu YT, Zhan SH, Tsai YT, Hsieh JF, Li LH, Hua KF, Wu SH. Galactomannan from Antrodia cinnamomea Enhances the Phagocytic Activity of Macrophages Organic letters 2017 [PMID: 28608692]
  6. Sahl JW, Sistrunk JR, Baby NI, Begum Y, Luo Q, Sheikh A, Qadri F, Fleckenstein JM, Rasko DA. Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology Scientific reports 7(1):3402 2017 [PMID: 28611468]
  7. Herry V, Gitton C, Tabouret G, Répérant M, Forge L, Tasca C, Gilbert FB, Guitton E, Barc C, Staub C, Smith DGE, Germon P, Foucras G, Rainard P. Local immunization impacts the response of dairy cows to Escherichia coli mastitis Scientific reports 7(1):3441 2017 [PMID: 28611405]
  8. Uotani Y, Kitahara R, Imai T, Tsutsumi N, Sasakawa C, Nagai S, Nagano T. Efficacy of an avian colibacillosis live vaccine for layer breeder in Japan The Journal of veterinary medical science 2017 [PMID: 28603216]
  9. Ma S, Zai J, Han Y, Hong Y, Zhang M, Cao X, Han Q, Lu K, Zhao Z, Lin J, Fu Z. Characterization of Schistosoma japonicum tetraspanning orphan receptor and its role in binding to complement C2 and immunoprotection against murine schistosomiasis Parasites & vectors 10(1):288 2017 [PMID: 28599669]
  10. Ouchenir L, Renaud C, Khan S, Bitnun A, Boisvert AA, McDonald J, Bowes J, Brophy J, Barton M, Ting J, Roberts A, Hawkes M, Robinson JL. The Epidemiology, Management, and Outcomes of Bacterial Meningitis in Infants Pediatrics 2017 [PMID: 28600447]
  11. Wang H, Liu R, Zhang W, Sun L, Ning Z, Ji F, Cui J, Zhang G. Identification of epitopes on nonstructural protein 7 of porcine reproductive and respiratory syndrome virus recognized by monoclonal antibodies using phage-display technology Virus genes 2017 [PMID: 28597195]
  12. Li H, Onbe K, Liu Q, Iijima M, Tatematsu K, Seno M, Tada H, Kuroda SI. Synthesis and assembly of Hepatitis B virus envelope protein-derived particles in Escherichia coli Biochemical and biophysical research communications 2017 [PMID: 28601634]
  13. Wyatt LS, Xiao W, Americo JL, Earl PL, Moss B. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins mBio 8(3) 2017 [PMID: 28588133]
  14. Porter CK, Louis Bourgeois A, Frenck RW, Prouty M, Maier N, Riddle MS. Developing and utilizing controlled human models of infection Vaccine 2017 [PMID: 28583306]
  15. Goffin P, Dehottay P. Complete Genome Sequence of <i>Escherichia coli</i> BLR(DE3), a <i>recA</i>-Deficient Derivative of <i>E. coli</i> BL21(DE3) Genome announcements 5(22) 2017 [PMID: 28572319]
  16. Xiang ZH, Sun RF, Lin C, Chen FZ, Mai JT, Liu YX, Xu ZY, Zhang L, Liu J. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins Frontiers in cellular and infection microbiology 7:226 2017 [PMID: 28620588]
  17. Hooda Y, Lai CCL, Moraes TF. Identification of a Large Family of Slam-Dependent Surface Lipoproteins in Gram-Negative Bacteria Frontiers in cellular and infection microbiology 7:207 2017 [PMID: 28620585]
  18. Afrouzan H, Azar T, Zakeri S, Ali EH. Chemical Composition and Antimicrobial Activities of Iranian Propolis Iranian biomedical journal 2017 [PMID: 28558440]
  19. Duan Q, Zhang W. Genetic fusion protein 3×STa-ovalbumin is an effective coating antigen in ELISA to titrate anti-STa antibodies Microbiology and immunology 2017 [PMID: 28561305]

Francisella tularensis (Tularemia)

  1. Parashar K, Kopping E, Frank D, Sampath V, Thanassi DG, Carpino N. Increased resistance to intradermal <i>Francisella tularensis LVS</i> infection by inactivation of the Sts phosphatases Infection and immunity 2017 [PMID: 28630061]
  2. Ryan DA, Degardin M, Alam S, Kissner TL, Hale M, Cameron MD, Rebek M, Ajami D, Saikh KU, Rebek J Jr. Rational Design of Peptide Derivatives for Inhibition of MyD88-Mediated TLR Signaling in Human PBMCs and Epithelial Cells Exposed to F. tularensis Chemical biology & drug design 2017 [PMID: 28599094]
  3. Esfandiari B, Nahrevanian H, Pourshafie MR, Gouya MM, Khaki P, Mostafavi E, Darvish J, Hanifi H. Epidemiological Distribution of Rodents as Potent Reservoirs for Infectious Diseases in the Provinces of Mazandaran, Gilan and Golestan, Northern Iran Infectious disease reports 9(2):6900 2017 [PMID: 28626537]
  4. Freudenberger Catanzaro KC, Champion AE, Mohapatra N, Cecere T, Inzana TJ. Glycosylation of a Capsule-Like Complex (CLC) by <i>Francisella novicida</i> Is Required for Virulence and Partial Protective Immunity in Mice Frontiers in microbiology 8:935 2017 [PMID: 28611741]

Hantavirus

  1. Sankar S, Ramamurthy M, Nandagopal B, Sridharan G. T-cell epitopes predicted from the Nucleocapsid protein of Sin Nombre virus restricted to 30 HLA alleles common to the North American population Bioinformation 13(3):94-9100 2017 [PMID: 28584450]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. . Correction to: Mbatha et al., High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination Infectious diseases (London, England) 49(9):719 2017 [PMID: 28562137]
  2. Chand S, Messina EL, AlSalmi W, Ananthaswamy N, Gao G, Uritskiy G, Padilla-Sanchez V, Mahalingam M, Peachman KK, Robb ML, Rao M, Rao VB. Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin Virology 508:199-212 2017 [PMID: 28577856]
  3. Kim J, Jobe O, Peachman KK, Michael NL, Robb ML, Rao M, Rao VB. Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies Virology 508:188-198 2017 [PMID: 28577855]
  4. Oliver SE, Hoots BE, Paz-Bailey G, Markowitz LE, Meites E. Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men-National HIV Behavioral Surveillance, United States, 2014 Journal of acquired immune deficiency syndromes (1999) 75 Suppl 3:S370-S374 2017 [PMID: 28604441]
  5. Atun R, Silva S, Knaul FM. Innovative financing instruments for global health 2002-15: a systematic analysis The Lancet. Global health 5(7):e720-e726 2017 [PMID: 28619230]
  6. Zhang Y, Niu Y, Tian JQ, Liu X, Yao X, Liu H. The glycans-mediated mechanism on the interactions of gp120 with CD4 and antibody: insights from molecular dynamics simulation Chemical biology & drug design 2017 [PMID: 28632942]
  7. Victora GD, Mouquet H. What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Lessons from the Antibody Response to HIV-1 Cold Spring Harbor perspectives in biology 2017 [PMID: 28630079]
  8. Kelsoe G, Haynes BF. What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Breaking through Immunity's Glass Ceiling Cold Spring Harbor perspectives in biology 2017 [PMID: 28630077]
  9. Stamper CT, Wilson PC. What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Is Affinity Maturation a Self-Defeating Process for Eliciting Broad Protection? Cold Spring Harbor perspectives in biology 2017 [PMID: 28630076]
  10. El-Sadr WM, Donnell D, Beauchamp G, Hall HI, Torian LV, Zingman B, Lum G, Kharfen M, Elion R, Leider J, Gordin FM, Elharrar V, Burns D, Zerbe A, Gamble T, Branson B. Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065) JAMA internal medicine 2017 [PMID: 28628702]
  11. Li T, Liu L, Wu H, Chen S, Zhu Q, Gao H, Yu X, Wang Y, Su W, Yao X, Peng T. Anti-herpes simplex virus type 1 activity of Houttuynoid A, a new flavonoid from Houttuynia cordata Thunb Antiviral research 2017 [PMID: 28629987]
  12. Higdon MM, Le T, O'Brien KL, Murdoch DR, Prosperi C, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Howie SRC, Kotloff KL, Levine OS, Scott JAG, Thea DM, Awori JO, Baillie VL, Cascio S, Chuananon S, DeLuca AN, Driscoll AJ, Ebruke BE, Endtz HP, Kaewpan A, Kahn G, Karani A, Karron RA, Moore DP, Park DE, Rahman MZ, Salaudeen R, Seidenberg P, Somwe SW, Sylla M, Tapia MD, Zeger SL, Deloria Knoll M, Madhi SA. Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged &lt;5 Years in the PERCH Study Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64(suppl_3):S378-S386 2017 [PMID: 28575375]
  13. Park DE, Baggett HC, Howie SRC, Shi Q, Watson NL, Brooks WA, Deloria Knoll M, Hammitt LL, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Scott JAG, Thea DM, Ahmed D, Antonio M, Baillie VL, DeLuca AN, Driscoll AJ, Fu W, Gitahi CW, Olutunde E, Higdon MM, Hossain L, Karron RA, Maiga AA, Maloney SA, Moore DP, Morpeth SC, Mwaba J, Mwenechanya M, Prosperi C, Sylla M, Thamthitiwat S, Zeger SL, Feikin DR. Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64(suppl_3):S328-S336 2017 [PMID: 28575367]
  14. Liu Q, Zhou S, Fan C, Huang W, Li Q, Liu S, Wu X, Li B, Wang Y. Biodistribution and residence time of adenovector serotype 5 in normal and immunodeficient mice and rats detected with bioluminescent imaging Scientific reports 7(1):3597 2017 [PMID: 28620164]
  15. Dingens AS, Haddox HK, Overbaugh J, Bloom JD. Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody Cell host & microbe 21(6):777-787.e4 2017 [PMID: 28579254]
  16. Sebastian MP, Dasgupta A, Saraswati LR, Singh A, Sharma V, Madan I, Tun W, Pulerwitz J, Thior I, Sarna A. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India Harm reduction journal 14(1):38 2017 [PMID: 28615077]
  17. McLean MR, Madhavi V, Wines BD, Hogarth PM, Chung AW, Kent SJ. Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial Journal of immunology (Baltimore, Md. : 1950) 2017 [PMID: 28615419]
  18. Powell RLR, Totrov M, Itri V, Liu X, Fox A, Zolla-Pazner S. Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer Journal of virology 2017 [PMID: 28615206]
  19. Wagner GA, Landais E, Caballero G, Phung P, Kosakovsky Pond SL, Poignard P, Richman DD, Little SJ, Smith DM. Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response Journal of virology 2017 [PMID: 28615205]
  20. Alsahafi N, Richard J, Prévost J, Coutu M, Brassard N, Parsons MS, Kaufmann DE, Brockman M, Finzi A. Impaired downregulation of NKG2D ligands by Nef protein from elite controllers sensitizes HIV-1-infected cells to ADCC Journal of virology 2017 [PMID: 28615199]
  21. Cairns TM, Ditto NT, Lou H, Brooks BD, Atanasiu D, Eisenberg RJ, Cohen GH. Global sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging PLoS pathogens 13(6):e1006430 2017 [PMID: 28614387]
  22. Solomon D, Stanley M, Robinson AJ. Anal cancer in women: are we appropriately identifying the risks? Sexually transmitted infections 2017 [PMID: 28601793]
  23. Kadkhodayan S, Jafarzade BS, Sadat SM, Motevalli F, Agi E, Bolhassani A. Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model Immunology letters 188:38-45 2017 [PMID: 28602843]
  24. Bradley T, Pollara J, Santra S, Vandergrift N, Pittala S, Bailey-Kellogg C, Shen X, Parks R, Goodman D, Eaton A, Balachandran H, Mach LV, Saunders KO, Weiner JA, Scearce R, Sutherland LL, Phogat S, Tartaglia J, Reed SG, Hu SL, Theis JF, Pinter A, Montefiori DC, Kepler TB, Peachman KK, Rao M, Michael NL, Suscovich TJ, Alter G, Ackerman ME, Moody MA, Liao HX, Tomaras G, Ferrari G, Korber BT, Haynes BF. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge Nature communications 8:15711 2017 [PMID: 28593989]
  25. Bale S, Goebrecht G, Stano A, Wilson R, Ota T, Tran K, Ingale J, Zwick MB, Wyatt RT. Covalent linkage of HIV-1 trimers to synthetic liposomes elicits improved B cell and antibody responses Journal of virology 2017 [PMID: 28592540]
  26. Sparks R, Koelle DM, Stern JE, Dhanireddy S. Elevated Spontaneous Interferon-γ Secretion in Human Immunodeficiency Virus-Infected Persons Open forum infectious diseases 4(2):ofx055 2017 [PMID: 28616443]
  27. Liang F, Lindgren G, Sandgren KJ, Thompson EA, Francica JR, Seubert A, De Gregorio E, Barnett S, O'Hagan DT, Sullivan NJ, Koup RA, Seder RA, Loré K. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake Science translational medicine 9(393) 2017 [PMID: 28592561]
  28. van den Ende C, Marano C, van Ahee A, Bunge EM, De Moerlooze L. The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience Expert review of vaccines 2017 [PMID: 28586278]
  29. Silva GP, Santos RS, Pereira-Manfro WF, Ferreira B, Barreto DM, Frota ACC, Hofer CB, Milagres LG. A cross-reacting material CRM<sub>197</sub> conjugate vaccine induces diphtheria toxin neutralizing antibody response in children and adolescents infected or not with HIV Vaccine 2017 [PMID: 28599793]
  30. Montserrat M, Plana M, Guardo AC, Andrés C, Climent N, Gallart T, Leal L, Gatell JM, Sánchez-Palomino S, García F. Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients AIDS (London, England) 2017 [PMID: 28590333]
  31. Genito CJ, Beck Z, Phares TW, Kalle F, Limbach KJ, Stefaniak ME, Patterson NB, Bergmann-Leitner ES, Waters NC, Matyas GR, Alving CR, Dutta S. Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013 Vaccine 2017 [PMID: 28596090]
  32. Xia L, Tang A, Meng W, Freed DC, He L, Wang D, Li F, Li L, Xiong W, Gui X, Schultz RD, Chen H, He X, Swoyer R, Ha S, Liu Y, Morris CD, Zhou Y, Wang IM, Zhao Q, Luo W, Xia N, Espeseth AS, Hazuda DJ, Rupp RE, Barrett AD, Zhang N, Zhu J, Fu TM, An Z. Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection Oncotarget 2017 [PMID: 28621685]
  33. Kumakech E, Andersson S, Wabinga H, Musubika C, Kirimunda S, Berggren V. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study BMC women's health 17(1):40 2017 [PMID: 28576143]
  34. Lionakis MS, Iliev ID, Hohl TM. Immunity against fungi JCI insight 2(11) 2017 [PMID: 28570272]
  35. Barbian HJ, Jackson-Jewett R, Brown CS, Bibollet-Ruche F, Learn GH, Decker T, Kreider EF, Li Y, Denny TN, Sharp PM, Shaw GM, Lifson J, Acosta EP, Saag MS, Bar KJ, Hahn BH. Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee Retrovirology 14(1):35 2017 [PMID: 28576126]
  36. Wang C, Jiang C, Gao N, Zhang K, Liu D, Wang W, Cong Z, Qin C, Ganusov VV, Ferrari G, LaBranche C, Montefiori DC, Kong W, Yu X, Gao F. Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine Viruses 9(6) 2017 [PMID: 28574482]
  37. Neto LFDSP, Vieira JV, Ronchi NR. Vaccination coverage in a cohort of HIV-infected patients receiving care at an AIDS outpatient clinic in Espírito Santo, Brazil The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2017 [PMID: 28579170]
  38. Gamble T, Branson B, Donnell D, Hall HI, King G, Cutler B, Hader S, Burns D, Leider J, Wood AF, G Volpp K, Buchacz K, El-Sadr WM. Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States Clinical trials (London, England) :1740774517711682 2017 [PMID: 28627929]
  39. Zhu Y, Guo Y, Du S, Liu C, Wang M, Ren D, Zhao F, Zhang Y, Sun W, Li Y, Cao T, Jiang Y, Xing B, Bai B, Li C, Jin N. Construction, Selection and Immunogenicity of Recombinant Fowlpox Candidate Vaccine Co-expressing HIV-1 gag and gp145 Indian journal of microbiology 57(2):162-170 2017 [PMID: 28611493]
  40. Navalkele BD, Henig O, Fairfax M, Flanagan E, Upfal M, Russell J, Dhar S, Kaye K, Chopra T. First Case of Vaccine-strain Varicella Infection as Manifestation of HIV in Healthcare worker: A Case Report and Review of the Literature The Journal of hospital infection 2017 [PMID: 28579471]
  41. Seybold U. [Vaccines for people living with HIV/AIDS] MMW Fortschritte der Medizin 159(Suppl 2):23-27 2017 [PMID: 28597270]
  42. Iyer SS, Sabula MJ, Mehta CC, Haddad LB, Brown NL, Amara RR, Ofotokun I, Sheth AN. Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women PloS one 12(6):e0178193 2017 [PMID: 28570576]
  43. Lima NS, Rolland M, Modjarrad K, Trautmann L. T Cell Immunity and Zika Virus Vaccine Development Trends in immunology 2017 [PMID: 28579320]
  44. Mutucumarana CP, Eudailey J, McGuire EP, Vandergrift N, Tegha G, Chasela C, Ellington S, van der Horst C, Kourtis AP, Permar SR, Fouda GG. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals Clinical and vaccine immunology : CVI 2017 [PMID: 28566336]
  45. Foreman TW, Mehra S, Lackner AA, Kaushal D. Translational Research in the Nonhuman Primate Model of Tuberculosis ILAR journal :1-9 2017 [PMID: 28575319]
  46. Murray SE, Nesterenko PA, Vanarsdall AL, Munks MW, Smart SM, Veziroglu EM, Sagario LC, Lee R, Claas FHJ, Doxiadis IIN, McVoy MA, Adler SP, Hill AB. Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans The Journal of experimental medicine 2017 [PMID: 28566275]
  47. Lin KY, Chen GJ, Lee YL, Huang YC, Cheng A, Sun HY, Chang SY, Liu CE, Hung CC. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review World journal of gastroenterology 23(20):3589-3606 2017 [PMID: 28611512]
  48. Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ. A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens Frontiers in immunology 8:595 2017 [PMID: 28596770]
  49. Gańczak M, Szych Z. [HBV, HCV, and HIV infection prevalence among prison staff in the light of occupational risk factors] Medycyna pracy 2017 [PMID: 28584337]
  50. Wong YY, Johnson B, Friedrich TC, Trepanier LA. Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk Pharmacology research & perspectives 5(3):e00312 2017 [PMID: 28603631]
  51. Joukar F, Mansour-Ghanaei F, Naghipour MR, Hasandokht T. Nurses' Knowledge toward Hepatitis B and Hepatitis C in Guilan, Iran The open nursing journal 11:34-42 2017 [PMID: 28567168]
  52. Almeida MC, Araújo FF, Ortega-Jacome GP, Tuboi SH, Fernandes GC. Operational research principles for a routine service process for monitoring the human immunodeficiency virus/acquired immunodeficiency syndrome treatment cascade: data from a cohort in Brazil Revista da Sociedade Brasileira de Medicina Tropical 50(2):229-234 2017 [PMID: 28562760]
  53. Denner J. Xenotransplantation - A special case of One Health One health (Amsterdam, Netherlands) 3:17-22 2017 [PMID: 28616498]
  54. Robert PA, Rastogi A, Binder SC, Meyer-Hermann M. How to Simulate a Germinal Center Methods in molecular biology (Clifton, N.J.) 1623:303-334 2017 [PMID: 28589364]
  55. Zubair S, Azhar A, Khan N, Ahmad E, Ajmal M, Owais M. Nanoparticle-Based Mycosis Vaccine Methods in molecular biology (Clifton, N.J.) 1625:169-211 2017 [PMID: 28584991]
  56. Paris RM, Milagres LG, Moysi E, Okulicz JF, Agan BK, Ganesan A, Petrovas C, Koup RA. Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection Pathogens & immunity 2(1):66-88 2017 [PMID: 28580437]
  57. Morey RJ, Collier MG, Nelson NP. The Financial Burden of Public Health Responses to Hepatitis A Cases Among Food Handlers, 2012-2014 Public health reports (Washington, D.C. : 1974) :33354917710947 2017 [PMID: 28609202]
  58. Luetkemeyer AF, Wyles DL. CROI 2017: Highlights of Advances in Viral Hepatitis and Liver Fibrosis Topics in antiviral medicine 25(2):84-92 2017 [PMID: 28598793]
  59. Jones J, Taylor BS, Tieu HV, Wilkin TJ. CROI 2017: Advances in Antiretroviral Therapy Topics in antiviral medicine 25(2):51-67 2017 [PMID: 28598790]
  60. Laramie AK, Bednarsh H, Isman B, Boiano JM, McCrone SH. Use of Bloodborne Pathogens Exposure Control Plans in Private Dental Practices: Results and Clinical Implications of a National Survey Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995) 38(6):398-407 2016 [PMID: 28570085]
  61. Dagnra AY, Mlaga KD, Adjoh K, Kadanga E, Disse K, Adekambi T. Prevalence of multidrug-resistant tuberculosis cases among HIV-positive and HIV-negative patients eligible for retreatment regimen in Togo using GeneXpert MTB/RIF New microbes and new infections 8:24-27 2015 [PMID: 28626586]

Lassa virus

  1. Hastie KM, Zandonatti MA, Kleinfelter LM, Heinrich ML, Rowland MM, Chandran K, Branco LM, Robinson JE, Garry RF, Saphire EO. Structural basis for antibody-mediated neutralization of Lassa virus Science (New York, N.Y.) 356(6341):923-928 2017 [PMID: 28572385]

Marburg virus

  1. Alharbi NK, Padron-Regalado E, Thompson CP, Kupke A, Wells D, Sloan MA, Grehan K, Temperton N, Lambe T, Warimwe G, Becker S, Hill AVS, Gilbert SC. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice Vaccine 35(30):3780-3788 2017 [PMID: 28579232]
  2. Duehr J, Wohlbold TJ, Oestereich L, Chromikova V, Amanat F, Rajendran M, Gomez-Medina S, Mena I, TenOever BR, García-Sastre A, Basler CF, Munoz-Fontela C, Krammer F. Novel cross-reactive monoclonal antibodies against Ebolavirus glycoproteins show protection in a murine challenge model Journal of virology 2017 [PMID: 28592526]
  3. Furuyama W, Miyamoto H, Yoshida R, Takada A. Quantification of Filovirus Glycoprotein-Specific Antibodies Methods in molecular biology (Clifton, N.J.) 1628:309-320 2017 [PMID: 28573631]

Mycobacterium tuberculosis (tuberculosis)

  1. Atun R, Silva S, Knaul FM. Innovative financing instruments for global health 2002-15: a systematic analysis The Lancet. Global health 5(7):e720-e726 2017 [PMID: 28619230]
  2. Chancellor A, White A, Tocheva AS, Fenn JR, Dennis M, Tezera L, Singhania A, Elliott T, Tebruegge M, Elkington P, Gadola S, Sharpe S, Mansour S. Quantitative and qualitative iNKT repertoire associations with disease susceptibility and outcome in macaque tuberculosis infection Tuberculosis (Edinburgh, Scotland) 105:86-95 2017 [PMID: 28610792]
  3. Elnaggar MM, Abdellrazeq GS, Elsisy A, Mahmoud AH, Shyboub A, Sester M, Khaliel SA, Singh M, Torky HA, Davis WC. Evaluation of antigen specific interleukin-1β as a biomarker to detect cattle infected with Mycobacterium bovis Tuberculosis (Edinburgh, Scotland) 105:53-59 2017 [PMID: 28610788]
  4. Blazevic A, Xia M, Turan A, Tennant J, Hoft DF. Pilot studies of a human BCG challenge model Tuberculosis (Edinburgh, Scotland) 105:108-112 2017 [PMID: 28610781]
  5. Kaufmann SHE, Weiner J Rd, Maertzdorf J. Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers Expert review of vaccines :1-9 2017 [PMID: 28608729]
  6. Jia Q, Dillon BJ, Masleša-Galić S, Horwitz MA. Listeria-vectored vaccine expressing the <i>Mycobacterium tuberculosis</i> 30 kDa major secretory protein via the constitutively active <i>prfA</i>* regulon boosts BCG efficacy against tuberculosis Infection and immunity 2017 [PMID: 28630063]
  7. Park DE, Baggett HC, Howie SRC, Shi Q, Watson NL, Brooks WA, Deloria Knoll M, Hammitt LL, Kotloff KL, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Scott JAG, Thea DM, Ahmed D, Antonio M, Baillie VL, DeLuca AN, Driscoll AJ, Fu W, Gitahi CW, Olutunde E, Higdon MM, Hossain L, Karron RA, Maiga AA, Maloney SA, Moore DP, Morpeth SC, Mwaba J, Mwenechanya M, Prosperi C, Sylla M, Thamthitiwat S, Zeger SL, Feikin DR. Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64(suppl_3):S328-S336 2017 [PMID: 28575367]
  8. Moore DP, Higdon MM, Hammitt LL, Prosperi C, DeLuca AN, Da Silva P, Baillie VL, Adrian PV, Mudau A, Deloria Knoll M, Feikin DR, Murdoch DR, O'Brien KL, Madhi SA. The Incremental Value of Repeated Induced Sputum and Gastric Aspirate Samples for the Diagnosis of Pulmonary Tuberculosis in Young Children With Acute Community-Acquired Pneumonia Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64(suppl_3):S309-S316 2017 [PMID: 28575364]
  9. Liang Y, Zhang J, Yang Y, Bai X, Yu Q, Li N, Hou Y, Shi Y, Wang L, Wu X. Immunogenicity and therapeutic effects of recombinant Ag85AB fusion protein vaccines in mice infected with Mycobacterium tuberculosis Vaccine 2017 [PMID: 28625522]
  10. Moguche AO, Musvosvi M, Penn-Nicholson A, Plumlee CR, Mearns H, Geldenhuys H, Smit E, Abrahams D, Rozot V, Dintwe O, Hoff ST, Kromann I, Ruhwald M, Bang P, Larson RP, Shafiani S, Ma S, Sherman DR, Sette A, Lindestam Arlehamn CS, McKinney DM, Maecker H, Hanekom WA, Hatherill M, Andersen P, Scriba TJ, Urdahl KB. Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis Cell host & microbe 21(6):695-706.e5 2017 [PMID: 28618268]
  11. Barber DL. The Helper T Cell's Dilemma in Tuberculosis Cell host & microbe 21(6):655-656 2017 [PMID: 28618262]
  12. Huang CY, Hsieh WY. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis Human vaccines & immunotherapeutics :0 2017 [PMID: 28604170]
  13. Belo C, Naidoo S. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Nampula Central Hospital, Mozambique BMC infectious diseases 17(1):408 2017 [PMID: 28595594]
  14. Wang X, Chen S, Xu Y, Zheng H, Xiao T, Li Y, Chen X, Huang M, Zhang H, Fang X, Jiang Y, Li M, Liu H, Wan K. Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis Emerging microbes & infections 6(6):e48 2017 [PMID: 28588287]
  15. Sparks R, Koelle DM, Stern JE, Dhanireddy S. Elevated Spontaneous Interferon-γ Secretion in Human Immunodeficiency Virus-Infected Persons Open forum infectious diseases 4(2):ofx055 2017 [PMID: 28616443]
  16. Li J, Shen J, Lao S, Li X, Liu J, Wu C. <b><i>Mycobacterium</i></b><b><i>tuberculosis</i> Rv3615c is a highly immunodominant antigen and specifically induce</b><b>s</b><b>potent Th1-type immune responses in tuberculosis pleurisy</b> Clinical science (London, England : 1979) 2017 [PMID: 28588103]
  17. Jensen C, Lindebo Holm L, Svensson E, Aagaard C, Ruhwald M. Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis Scientific reports 7(1):2830 2017 [PMID: 28588268]
  18. Basaraba RJ, Hunter RL. Pathology of Tuberculosis: How the Pathology of Human Tuberculosis Informs and Directs Animal Models Microbiology spectrum 5(3) 2017 [PMID: 28597826]
  19. Michelsen SW, Soborg B, Diaz LJ, Hoff ST, Agger EM, Koch A, Rosenkrands I, Wohlfahrt J, Melbye M. The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders PloS one 12(6):e0177906 2017 [PMID: 28570574]
  20. Xiang ZH, Sun RF, Lin C, Chen FZ, Mai JT, Liu YX, Xu ZY, Zhang L, Liu J. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins Frontiers in cellular and infection microbiology 7:226 2017 [PMID: 28620588]
  21. Foreman TW, Mehra S, Lackner AA, Kaushal D. Translational Research in the Nonhuman Primate Model of Tuberculosis ILAR journal :1-9 2017 [PMID: 28575319]
  22. Cossu D, Yokoyama K, Hattori N. Conflicting Role of <i>Mycobacterium</i> Species in Multiple Sclerosis Frontiers in neurology 8:216 2017 [PMID: 28579973]
  23. Yu Q, Wang X, Fan X. A New Adjuvant MTOM Mediates <i>Mycobacterium tuberculosis</i> Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2<sup>+</sup> T Cells Frontiers in immunology 8:585 2017 [PMID: 28572807]
  24. Chen H, Liu X, Ma X, Wang Q, Yang G, Niu H, Li S, He B, He S, Dannenberg AM Jr, Zhu B, Zhang Y. A New Rabbit-Skin Model to Evaluate Protective Efficacy of Tuberculosis Vaccines Frontiers in microbiology 8:842 2017 [PMID: 28567030]
  25. Liu W, Xu Y, Shen H, Yan J, Yang E, Wang H. Recombinant <i>Bacille Calmette-Guérin</i> coexpressing Ag85B-IFN-γ enhances the cell-mediated immunity in C57BL/6 mice Experimental and therapeutic medicine 13(5):2339-2347 2017 [PMID: 28565847]
  26. Jenkins AO, Michel A, Rutten V. Original Mycobacterial Sin, a consequence of highly homologous antigens? Veterinary microbiology 203:286-293 2017 [PMID: 28619159]
  27. Liu SJ, Jiang MJ, Pu QK, Ren CY, Su L, Zhang X, Wang C. [Prediction and Analysis of Epitopes in clpP2 of <i>Mycobacterium tuberculosis</i>] Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 48(2):244-247 2017 [PMID: 28612535]
  28. Ren CY, Liu SJ, Pu QK, Jiang MJ, Zhou MY, Wang C. [Genetic Recombiniation and Protein Expression Detection of <i>Listeria</i>-based <i>tuberculosis</i> Vaccine Candidates.] Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 47(6):819-824 2016 [PMID: 28598105]
  29. Dagnra AY, Mlaga KD, Adjoh K, Kadanga E, Disse K, Adekambi T. Prevalence of multidrug-resistant tuberculosis cases among HIV-positive and HIV-negative patients eligible for retreatment regimen in Togo using GeneXpert MTB/RIF New microbes and new infections 8:24-27 2015 [PMID: 28626586]

Nipah virus

  1. Hotard AL, He B, Nichol ST, Spiropoulou CF, Lo MK. 4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency Antiviral research 2017 [PMID: 28629988]

Plasmodium falciparum (Malaria)

  1. Mpina M, Maurice NJ, Yajima M, Slichter CK, Miller HW, Dutta M, McElrath MJ, Stuart KD, De Rosa SC, McNevin JP, Linsley PS, Abdulla S, Tanner M, Hoffman SL, Gottardo R, Daubenberger CA, Prlic M. Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations Journal of immunology (Baltimore, Md. : 1950) 199(1):107-118 2017 [PMID: 28576979]
  2. Atun R, Silva S, Knaul FM. Innovative financing instruments for global health 2002-15: a systematic analysis The Lancet. Global health 5(7):e720-e726 2017 [PMID: 28619230]
  3. Singh SK, Thrane S, Janitzek CM, Nielsen MA, Theander TG, Theisen M, Salanti A, Sander AF. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display Vaccine 35(30):3726-3732 2017 [PMID: 28578824]
  4. Ntege EH, Takashima E, Morita M, Nagaoka H, Ishino T, Tsuboi T. Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates Expert review of vaccines :1-11 2017 [PMID: 28604122]
  5. Leneghan DB, Miura K, Taylor IJ, Li Y, Jin J, Brune KD, Bachmann MF, Howarth M, Long CA, Biswas S. Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines Scientific reports 7(1):3811 2017 [PMID: 28630474]
  6. Vaughan AM, Kappe SHI. Genetically attenuated malaria parasites as vaccines Expert review of vaccines :1-3 2017 [PMID: 28612631]
  7. Das SC, Morales RAV, Seow J, Bankala K, Dissanayake R, Anders RF, MacRaild CA, Norton RS. Lipid interactions modulate the structural and antigenic properties of the C-terminal domain of the malaria antigen merozoite surface protein 2 The FEBS journal 2017 [PMID: 28618199]
  8. Payne RO, Silk SE, Elias SC, Milne KH, Rawlinson TA, Llewellyn D, Shakri AR, Jin J, Labbé GM, Edwards NJ, Poulton ID, Roberts R, Farid R, Jørgensen T, Alanine DG, de Cassan SC, Higgins MK, Otto TD, McCarthy JS, de Jongh WA, Nicosia A, Moyle S, Hill AV, Berrie E, Chitnis CE, Lawrie AM, Draper SJ. Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies JCI insight 2(12) 2017 [PMID: 28614791]
  9. McGuire KA, Miura K, Wiethoff CM, Williamson KC. New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission Malaria journal 16(1):254 2017 [PMID: 28619071]
  10. Rathnapala UL, Goodman CD, McFadden GI. A novel genetic technique in Plasmodium berghei allows liver stage analysis of genes required for mosquito stage development and demonstrates that de novo heme synthesis is essential for liver stage development in the malaria parasite PLoS pathogens 13(6):e1006396 2017 [PMID: 28617870]
  11. Nogueira RT, Sahi V, Huang J, Tsuji M. Human IgG repertoire of malaria antigen-immunized human immune system (HIS) mice Immunology letters 188:46-52 2017 [PMID: 28610800]
  12. Bei AK, Ahouidi AD, Dvorin JD, Miura K, Diouf A, Ndiaye D, Premji Z, Diakite M, Mboup S, Long CA, Duraisingh MT. Functional analysis reveals geographical variation in inhibitory immune responses against a polymorphic malaria antigen The Journal of infectious diseases 2017 [PMID: 28605544]
  13. Mehrizi AA, Torabi F, Zakeri S, Djadid ND. Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 53:239-247 2017 [PMID: 28600217]
  14. Lempereur L, Larcombe SD, Durrani Z, Karagenc T, Bilgic HB, Bakirci S, Hacilarlioglu S, Kinnaird J, Thompson J, Weir W, Shiels B. Identification of candidate transmission-blocking antigen genes in Theileria annulata and related vector-borne apicomplexan parasites BMC genomics 18(1):438 2017 [PMID: 28583072]
  15. Genito CJ, Beck Z, Phares TW, Kalle F, Limbach KJ, Stefaniak ME, Patterson NB, Bergmann-Leitner ES, Waters NC, Matyas GR, Alving CR, Dutta S. Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013 Vaccine 2017 [PMID: 28596090]
  16. Carter MJ, Mitchell RM, Meyer Sauteur PM, Kelly DF, Trück J. The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications Frontiers in immunology 8:630 2017 [PMID: 28620385]
  17. Kreutzfeld O, Müller K, Matuschewski K. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine Frontiers in cellular and infection microbiology 7:198 2017 [PMID: 28620583]
  18. Aggarwal A, Garg N. Newer Vaccines against Mosquito-borne Diseases Indian journal of pediatrics 2017 [PMID: 28560654]
  19. Afrouzan H, Azar T, Zakeri S, Ali EH. Chemical Composition and Antimicrobial Activities of Iranian Propolis Iranian biomedical journal 2017 [PMID: 28558440]
  20. Singh SK, Roeffen W, Mistarz UH, Chourasia BK, Yang F, Rand KD, Sauerwein RW, Theisen M. Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine Microbial cell factories 16(1):97 2017 [PMID: 28569168]
  21. Heidari Z, Arora JS, Datta D, John VT, Kumar N, Bansal GP. Impact of the Charge Ratio on the In Vivo Immunogenicity of Lipoplexes Pharmaceutical research 2017 [PMID: 28560696]
  22. van den Berg RA, Coccia M, Ballou WR, Kester KE, Ockenhouse CF, Vekemans J, Jongert E, Didierlaurent AM, van der Most RG. Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial Frontiers in immunology 8:557 2017 [PMID: 28588574]
  23. Gras S, Jackson A, Woods S, Pall G, Whitelaw J, Leung JM, Ward GE, Roberts CW, Meissner M. Parasites lacking the micronemal protein MIC2 are deficient in surface attachment and host cell egress, but remain virulent <i>in vivo</i> Wellcome open research 2:32 2017 [PMID: 28630943]
  24. Acharya P, Garg M, Kumar P, Munjal A, Raja KD. Host-Parasite Interactions in Human Malaria: Clinical Implications of Basic Research Frontiers in microbiology 8:889 2017 [PMID: 28572796]
  25. Murdock CC, Luckhart S, Cator LJ. Immunity, host physiology, and behaviour in infected vectors Current opinion in insect science 20:28-33 2017 [PMID: 28602233]
  26. Troiano G, Mercone A, Bagnoli A, Nante N. International Travelers' Sociodemographic, Health, and Travel Characteristics: An Italian Study Annals of global health 83(2):380-385 2017 [PMID: 28619415]
  27. Winskill P, Walker PG, Griffin JT, Ghani AC. Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa BMJ global health 2(1):e000090 2017 [PMID: 28588994]
  28. Paris RM, Milagres LG, Moysi E, Okulicz JF, Agan BK, Ganesan A, Petrovas C, Koup RA. Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection Pathogens & immunity 2(1):66-88 2017 [PMID: 28580437]

Salmonella

  1. Wang Y, Li J, Xiong K, Chen Z, Zheng C, Tan Y, Cong Y. Elimination of persistent vaccine bacteria of Salmonella enterica serovar Typhimurium in the guts of immunized mice by inducible expression of truncated YncE PloS one 12(6):e0179649 2017 [PMID: 28628661]
  2. Ye X, Zhang GL, Yang L, Zhu J. Synthesis and Antigenic Evaluation of Oligosaccharide Mimics of Vi Antigen from Salmonella typhi Chemistry (Weinheim an der Bergstrasse, Germany) 2017 [PMID: 28622429]
  3. Goswami N, Hussain MI, Borah P. Molecular dynamics approach to probe the antigenicity of PagN - an outer membrane protein of Salmonella Typhi Journal of biomolecular structure & dynamics :1-41 2017 [PMID: 28617661]
  4. Gayet R, Bioley G, Rochereau N, Paul S, Corthésy B. Vaccination against Salmonella Infection: the Mucosal Way Microbiology and molecular biology reviews : MMBR 81(3) 2017 [PMID: 28615285]
  5. Kamble NM, Hyoung KJ, Lee JH. Live-attenuated auxotrophic mutant of Salmonella typhimurium expressing immunogenic HA1 protein enhances immunity and protective efficacy against H1N1 influenza virus infection Future microbiology 2017 [PMID: 28594235]
  6. Bausch-Jurken MT, Verbsky JW, Gonzaga KA, Elms NP, Hintermeyer MK, Gauld SB, Routes JM. The Use of Salmonella Typhim Vaccine to Diagnose Antibody Deficiency Journal of clinical immunology 2017 [PMID: 28589420]
  7. Carreño JM, Perez-Shibayama C, Gil-Cruz C, Lopez-Macias C, Vernazza P, Ludewig B, Albrich WC. Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial PloS one 12(6):e0178669 2017 [PMID: 28570603]
  8. Lalsiamthara J, Lee JH. Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge Veterinary microbiology 205:84-91 2017 [PMID: 28622869]
  9. Hajam IA, Lee JH. Preexisting Salmonella-specific immunity interferes with the subsequent development of immune responses against the Salmonella strains delivering H9N2 hemagglutinin Veterinary microbiology 205:117-123 2017 [PMID: 28622853]
  10. Rochat L, Croxatto A, De Vallière S, D'Acremont V, Genton B. Multiplex PCR gastro-intestinal panels for the management of traveller's diarrhea : are they accurate and useful? Revue medicale suisse 13(561):963-967 2017 [PMID: 28627855]

Shigella

  1. Chowdhury FM, Rahman MZ, Sarkar MMH, Rabbi F, Khan SI, Ahsan CR, Birkeland NK. Protection against shigellosis caused by Shigella dysenteriae serotype 4 in guinea pigs using Escherichia albertii DM104 as a live vaccine candidate strain Acta microbiologica et immunologica Hungarica :1-14 2017 [PMID: 28597684]
  2. Porter CK, Louis Bourgeois A, Frenck RW, Prouty M, Maier N, Riddle MS. Developing and utilizing controlled human models of infection Vaccine 2017 [PMID: 28583306]
  3. Platts-Mills JA, Amour C, Gratz J, Nshama R, Walongo T, Mujaga B, Maro A, McMurry TL, Liu J, Mduma E, Houpt ER. Impact of rotavirus vaccine introduction and post-introduction etiology of diarrhea requiring hospital admission in Haydom, Tanzania, a rural African setting Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 [PMID: 28575304]
  4. McArthur MA, Maciel M Jr, Pasetti MF. Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward Vaccine 2017 [PMID: 28558984]
  5. Rochat L, Croxatto A, De Vallière S, D'Acremont V, Genton B. Multiplex PCR gastro-intestinal panels for the management of traveller's diarrhea : are they accurate and useful? Revue medicale suisse 13(561):963-967 2017 [PMID: 28627855]

Variola major (Smallpox)

  1. Martínez O, Bravo Cruz A, Santos S, Ramírez M, Miranda E, Shisler J, Otero M. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge Vaccine 2017 [PMID: 28629922]
  2. Achdout H, Lustig S, Israely T, Erez N, Politi B, Tamir H, Israeli O, Waner T, Melamed S, Paran N. Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models Vaccine 2017 [PMID: 28625523]
  3. Phelps A, Gates AJ, Eastaugh L, Hillier M, Ulaeto DO. Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model Vaccine 2017 [PMID: 28606813]
  4. Wyatt LS, Xiao W, Americo JL, Earl PL, Moss B. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins mBio 8(3) 2017 [PMID: 28588133]
  5. Kwanchum K, Ampol S, Thongput A, Horthongkham N, Udomphunthurak S, Siritantikorn S, Kantakamalakul W. Duration of neutralizing antibody persisting in Thai individuals after childhood vaccination against smallpox Asian Pacific journal of allergy and immunology 2017 [PMID: 28577520]
  6. Shi B, Qiu H, Niu W, Ren Y, Ding H, Chen D. Voluntary Vaccination through Self-organizing Behaviors on Locally-mixed Social Networks Scientific reports 7(1):2665 2017 [PMID: 28572623]
  7. Di Pietro ML, Poscia A, Teleman AA, Maged D, Ricciardi W. Vaccine hesitancy: parental, professional and public responsibility Annali dell'Istituto superiore di sanita 53(2):157-162 2017 [PMID: 28617263]

Venezuelan equine encephalitis virus

  1. Gayen M, Gupta P, Morazzani EM, Gaidamakova EK, Knollmann-Ritschel B, Daly MJ, Glass PJ, Maheshwari RK. Deinococcus Mn<sup>2+</sup>-peptide complex: A novel approach to alphavirus vaccine development Vaccine 35(29):3672-3681 2017 [PMID: 28576570]
  2. Bounds CE, Terry FE, Moise L, Hannaman D, Martin WD, De Groot AS, Suschak JJ, Dupuy LC, Schmaljohn CS. An immunoinformatics-derived DNA vaccine encoding human Class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice Human vaccines & immunotherapeutics :0 2017 [PMID: 28575582]

Vibrio cholerae

  1. Cabrera A, Lepage JE, Sullivan KM, Seed SM. Vaxchora: A Single-Dose Oral Cholera Vaccine The Annals of pharmacotherapy 51(7):584-589 2017 [PMID: 28622736]

Yersinia pestis (Plague)

  1. Zvi A, Rotem S, Zauberman A, Elia U, Aftalion M, Bar-Haim E, Mamroud E, Cohen O. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague Vaccine 2017 [PMID: 28606812]
  2. Madan-Lala R, Pradhan P, Roy K. Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses Scientific reports 7(1):2530 2017 [PMID: 28566683]

Click HERE to see the publications in the last month.